Search Results - "Plana, Josep Maria Campistol"
-
1
Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial
Published in Clinical infectious diseases (02-01-2020)“…Abstract Background The incidence of herpes zoster is up to 9 times higher in immunosuppressed solid organ transplant recipients than in the general…”
Get full text
Journal Article -
2
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update
Published in Journal of neurology (01-12-2022)“…© The Author(s) 2022 Open Access This article is licensed under a Creative Commons Attri- bution 4.0 International License, which permits use, sharing, adapta-…”
Get full text
Journal Article -
3
2908 Renal progenitor cells an early non-invasive biomarker of silent kidney injury in Fabry disease
Published in Nephrology, dialysis, transplantation (23-05-2024)“…Abstract Background and Aims Fabry's disease (FD), a hereditary condition, is linked to the X chromosome due to a mutation in the gene encoding…”
Get full text
Journal Article -
4
3006 Therapeutic apheresis in Fabry disease
Published in Nephrology, dialysis, transplantation (23-05-2024)“…Abstract Background and Aims Fabry's disease (FD) is a rare lysosomal disorder linked to the X chromosome due to a mutation in the gene encoding…”
Get full text
Journal Article -
5
Adoptive Cellular Immunotherapy for the Control of Primary Membranous Nephropathy: FR-OR60
Published in Journal of the American Society of Nephrology (01-11-2023)Get full text
Journal Article -
6
Early data on long‐term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2‐year update from the open‐label extension of the NEURO‐TTR trial
Published in European journal of neurology (01-08-2020)“…Background and purpose Hereditary transthyretin (hATTR) amyloidosis causes progressive polyneuropathy resulting from transthyretin (TTR) amyloid deposition…”
Get full text
Journal Article -
7
Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update
Published in Orphanet journal of rare diseases (18-06-2022)“…Abstract Background Transthyretin amyloidosis (ATTR amyloidosis) is a rare, life-threatening disease caused by the accumulation of variant or wild-type (ATTRwt…”
Get full text
Journal Article -
8
FC 110: Survival Benefit of Preemptive Simultaneous Pancreas-Kidney Transplantation
Published in Nephrology, dialysis, transplantation (03-05-2022)“…Abstract BACKGROUND AND AIMS The evidence regarding the benefits of performing preemptive SPK (pSPK) is controversial. The aim of the present study was to…”
Get full text
Journal Article -
9
Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)
Published in PloS one (06-04-2017)“…Cardiac troponins and natriuretic peptides are established for risk stratification in light-chain amyloidosis. Data on cardiac biomarkers in transthyretin…”
Get full text
Journal Article -
10
P0664CKDSENS, A NOVEL HEALTHCARE PLATFORM FOR CHRONIC KIDNEY DISEASE
Published in Nephrology, dialysis, transplantation (01-06-2020)“…Abstract Background and Aims The 10% of the global adult population, more than 730 million people, suffers from some degree of chronic kidney disease (CKD)…”
Get full text
Journal Article -
11
Efficacy and safety with >3 years of inotersen treatment for the polyneuropathy of hereditary transthyretin amyloidosis
Published in Journal of the neurological sciences (01-10-2021)Get full text
Journal Article -
12
Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
Published in JACC CardioOncology (01-10-2021)“…Transthyretin amyloid cardiomyopathy results from the accumulation of wild-type (ATTRwt) or variant (ATTRv) transthyretin amyloid fibrils in the myocardium…”
Get full text
Journal Article -
13
Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
Published in Neurology and therapy (01-12-2021)“…Introduction Hereditary transthyretin amyloidosis (ATTRv amyloidosis) is a clinically heterogeneous disease caused by mutations in the transthyretin ( TTR )…”
Get full text
Journal Article -
14
Clinical and Genotype Characteristics and Symptom Migration in Patients With Mixed Phenotype Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey
Published in Cardiology and therapy (01-03-2024)“…Introduction Transthyretin amyloidosis (ATTR amyloidosis) is primarily associated with a cardiac or neurologic phenotype, but a mixed phenotype is increasingly…”
Get full text
Journal Article -
15